A Pioneer Model for Nurturing Education in Immunology


A Pioneer Model for Nurturing Education in Immunology

In 1991 Serafino Zappacosta, Professor of Immunology at the Federico II University of Naples, founded the “Scuola Superiore di Immunologia Ruggero Ceppellini” (defined herein as the Ceppellini School, CS). The school was founded with the aim of fostering education in Immunology at the international level and to attract young scientists to the discipline. The foundation of CS was a major breakthrough in accelerating Immunology education and it rapidly became a powerful attractive pole for the immunological community. It was also highly influential for the subsequent evolution of other international schools of immunology.

From its roots in the South of Italy, over the years CS has hosted top leaders in its board and faculty, and has attracted hundreds of young and enthusiastic participants from Western countries, the Middle East, Africa and India. A key objective of the CS was to recognize superlative work even before it was appreciated by others in the field. For example, Dr. Ralph Steinman gave a CS lecture on Dendritic Cells in 1999 and in 2011 he was awarded the Nobel Prize in Physiology or Medicine. More then a decade after Prof. Zappacosta’s sudden departure in 2006, the international prestige of CS is still strongly recognized worldwide. Indeed, many faculty members and students of the CS have the tendency to return to share their latest research in the ever growing field of Immunology. In 2007 Dr. Silvia Fontana-Zappacosta became the President of the CS, and in 2016 she was awarded honorary membership by the Italian Society of Immunology, Clinical Immunology and Allergology (SIICA) in recognition of her generous commitment in promoting education in Immunology, and of her success in pursuing the continuous progress of the CS.

We welcome the submission of articles that cover, but are not limited to, the following sub-topics:

1. Anti-tumor immunity.

2. Immunological memory and vaccines.

3. Immunity to intracellular bacteria.

4. Transplant immunology.

5. Adaptive Immunity.

6. Innate Immunity.

How we work:

  • After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days.
  • A 21 day window time frame is allotted for peer-review process wherein multiple experts are contacted.
  • Author proof is generated within 7 working days after the acceptance decision.

Benefits on Publication:

Open Access: Permanent free access to your article upon publication ensures extensive global reach and readership.

Easy Article Sharing: Our open access enables you to share your article directly with colleagues through email and on social media via a single link, permitting third party reuse with appropriate citation in addition to the retention of content copyright by the author.

Global Marketing: Through promotion in a targeted global email announcement or press release, your article will be seen by thousands of the top-most thought-leaders in your field.

Reprints: Distribute your work to colleagues and at conferences as we provide hard copy color reprints of your article on order.

Media Contact:
Stella M
Journal Manager
Immunome Research
Email: immunores@longdom.org